Stay updated with breaking news from Ecdna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of CareDx, Inc (NASDAQ:CDNA – Get Free Report) have been assigned a consensus rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price […]
CareDx, Inc (NASDAQ:CDNA – Get Free Report) has received an average rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month target price among brokers that have […]
CareDx, Inc (NASDAQ:CDNA – Get Free Report) was the target of a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 3,500,000 shares, a decline of 10.3% from the September 15th total of 3,900,000 shares. Based on an average daily volume of 742,300 shares, the […]
Cancer treatments for targeting tumor amplifications lag behind those targeting point mutations – and part of the reason may be that amplifications often reside on extrachromosomal DNA (ecDNA). Since ecDNA was first described back in 1965 as minute chromatin bodies in brain cancer cells, the use of large-scale DNA sequencing techniques has revealed the presence of ecDNA across a wide range of cancer types. “The circular structure of ecDNA is associated with increased proto-oncogenic capacity in comparison to linear amplifications. Another key feature is that ecDNA does not contain centrome...
StockNews.com started coverage on shares of CareDx (NASDAQ:CDNA – Free Report) in a research report sent to investors on Thursday. The firm issued a hold rating on the stock. A number of other analysts have also weighed in on the stock. HC Wainwright reiterated a neutral rating on shares of CareDx in a report on […]